Minimal Residual Disease Positive AML
1 clinical trials · Condition
◉ Watch Minimal Residual Disease Positive AML
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies (NCT02520427) | Amgen | 2015-08-31 |
Track Minimal Residual Disease Positive AML automatically
Every clearance here is in the API, with alerts when new ones post.